Epitope specificity and significance in systemic autoimmune diseases
暂无分享,去创建一个
[1] M. Fritzler,et al. Latest update on the Ro/SS-A autoantibody system. , 2009, Autoimmunity reviews.
[2] M. Fritzler,et al. The changing landscape of the clinical value of the PM/Scl autoantibody system , 2009, Arthritis research & therapy.
[3] I. Mackay,et al. Apotopes and the biliary specificity of primary biliary cirrhosis , 2009, Hepatology.
[4] J. Harley,et al. Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. , 2009, Arthritis and rheumatism.
[5] A. Cava. Lupus and T Cells , 2009 .
[6] Ş. Yavuz,et al. Comparative Performance Analysis of 4 Different Anti-Citrullinated Protein Assays in the Diagnosis of Rheumatoid Arthritis , 2009, The Journal of Rheumatology.
[7] D. Huscher,et al. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients , 2009, Arthritis research & therapy.
[8] R. Burlingame,et al. A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis , 2009, Clinical Rheumatology.
[9] E. Peeva,et al. B-cell-directed therapies in systemic lupus erythematosus. , 2008, Seminars in arthritis and rheumatism.
[10] M. Fritzler,et al. Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies , 2008, Arthritis research & therapy.
[11] Michael W. Jackson,et al. B cell apotopes of the 60-kDa Ro/SSA and La/SSB autoantigens. , 2008, Journal of autoimmunity.
[12] W. V. van Venrooij,et al. Anti‐CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis , 2008, Annals of the New York Academy of Sciences.
[13] V. Kraus,et al. Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study. , 2008, Osteoarthritis and cartilage.
[14] Marvin J Fritzler,et al. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. , 2008, Autoimmunity reviews.
[15] R. Cervera,et al. Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value. , 2008, Autoimmunity reviews.
[16] Ehud Shapiro,et al. De novo DNA synthesis using single molecule PCR , 2008, Nucleic acids research.
[17] R. H. Scofield,et al. Autoimmunity and oxidatively modified autoantigens. , 2008, Autoimmunity reviews.
[18] T. Witte. IgM Antibodies Against dsDNA in SLE , 2008, Clinical reviews in allergy & immunology.
[19] G. Steiner,et al. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease , 2008, Annals of the rheumatic diseases.
[20] A. Tincani,et al. Pathogenic anti-nucleosome antibodies , 2008, Lupus.
[21] R. Haigh,et al. Consequence of neo-antigenicity of the 'altered self'. , 2008, Rheumatology.
[22] S. Gabriel,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.
[23] F. Ohsuzu,et al. Primary biliary cirrhosis in female subjects with sicca-associated antibodies , 2007, Modern rheumatology.
[24] S. Svegliati,et al. Pathogenic autoantibodies in systemic sclerosis. , 2007, Current opinion in immunology.
[25] M. Fritzler,et al. Update on autoantibodies in systemic sclerosis , 2007, Current opinion in rheumatology.
[26] K. Kessenbrock,et al. Synthetic peptides: the future of patient management in systemic rheumatic diseases? , 2007, Current medicinal chemistry.
[27] K. Kessenbrock,et al. Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection , 2007, Journal of Molecular Medicine.
[28] Reinout Raijmakers,et al. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. , 2007, Autoimmunity reviews.
[29] D. Deforce,et al. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis , 2007, Annals of the rheumatic diseases.
[30] M. Fritzler,et al. Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus , 2007, Arthritis research & therapy.
[31] M. Petri,et al. Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus. , 2007, The Journal of rheumatology.
[32] M. Hudson,et al. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis , 2007, Clinical Rheumatology.
[33] S. Barr,et al. Autoantibodies in lupus nephritis patients requiring renal transplantation , 2007, Lupus.
[34] Michael J Taussig,et al. Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. , 2007, Journal of molecular biology.
[35] J. Buyon,et al. Different temporal expression of immunodominant Ro60/60 kDa‐SSA and La/SSB apotopes , 2007, Clinical and experimental immunology.
[36] R. Raijmakers,et al. Challenges and Controversies in Autoantibodies Associated with Systemic Rheumatic Diseases , 2007 .
[37] Lila Farrag,et al. A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein , 2007, Autoimmunity.
[38] J. Guthridge,et al. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. , 2006, Journal of autoimmunity.
[39] M. Gaubitz. Epidemiology of connective tissue disorders. , 2006, Rheumatology.
[40] J. Fisk,et al. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. , 2006, The Journal of rheumatology.
[41] G. Riemekasten,et al. The binding of lupus-derived autoantibodies to the C-terminal peptide (83–119) of the major SmD1 autoantigen can be mediated by double-stranded DNA and nucleosomes , 2006, Annals of the rheumatic diseases.
[42] C. Chichester,et al. Review: Collagen markers in early arthritic diseases. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[43] G. Tsokos. In the Beginning Was Sm , 2006, The Journal of Immunology.
[44] A. Tzioufas,et al. Autoantibodies to intracellular autoantigens and their B-cell epitopes: Molecular Probes to Study the Autoimmune Response , 2006, Critical reviews in clinical laboratory sciences.
[45] J. Harley,et al. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus , 2006, Autoimmunity.
[46] K. Kessenbrock,et al. International Multicenter Evaluation of Autoantibodies to Ribosomal P Proteins , 2006, Clinical and Vaccine Immunology.
[47] Wei Zhang,et al. A peptide DNA surrogate that binds and inhibits anti-dsDNA antibodies. , 2005, Clinical immunology.
[48] H. Bagavant,et al. Epitope spreading within lupus-associated ribonucleoprotein antigens. , 2005, Clinical immunology.
[49] G. Pruijn,et al. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen. , 2005, Autoimmunity reviews.
[50] H. Doyle,et al. Posttranslational Modifications of Self‐Antigens , 2005, Annals of the New York Academy of Sciences.
[51] R. Raijmakers,et al. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen , 2005, Arthritis research & therapy.
[52] S. Bombardieri,et al. Anti-Sm and anti-RNP antibodies , 2005, Autoimmunity.
[53] G. Pruijn,et al. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease , 2005, Arthritis research & therapy.
[54] M. Fritzler,et al. Improved Serological Differentiation between Systemic Lupus Erythematosus and Mixed Connective Tissue Disease by Use of an SmD3 Peptide-Based Immunoassay , 2005, Clinical Diagnostic Laboratory Immunology.
[55] M. Fritzler,et al. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies , 2004, Arthritis research & therapy.
[56] S. Pestka,et al. Spliceosome Sm proteins D1, D3, and B/B' are asymmetrically dimethylated at arginine residues in the nucleus. , 2004, Biochemical and biophysical research communications.
[57] Y. Shoenfeld,et al. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. , 2004, Seminars in arthritis and rheumatism.
[58] I. Sanz,et al. B cells as therapeutic targets for rheumatic diseases , 2004, Current opinion in rheumatology.
[59] E. Chan,et al. Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182 , 2003, Journal of Molecular Medicine.
[60] J. Koziol,et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. , 2003, The Journal of rheumatology.
[61] R Hal Scofield,et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.
[62] M. Mahler,et al. Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. , 2003, Clinical immunology.
[63] E. Chan,et al. A panel of monoclonal antibodies to cytoplasmic GW bodies and the mRNA binding protein GW182. , 2003, Hybridoma and hybridomics.
[64] R. Williams,et al. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins , 2003, Journal of Molecular Medicine.
[65] G. Pruijn,et al. Human recombinant anti-La (SS-B) autoantibodies demonstrate the accumulation of phosphoserine-366-containing la isoforms in nucleoplasmic speckles. , 2003, European journal of cell biology.
[66] H. Gausepohl,et al. Chemistry of Fmoc Peptide Synthesis on Membranes , 2002 .
[67] Hanspeter Herzel,et al. Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. , 2002, Journal of immunological methods.
[68] N. Ede. Multiple parallel synthesis of peptides on SynPhase grafted supports. , 2002, Journal of immunological methods.
[69] R. Frank. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. , 2002, Journal of immunological methods.
[70] M. Mahler,et al. Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis. , 2002, Arthritis and rheumatism.
[71] H. Ménard,et al. Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis? , 2002, Current opinion in rheumatology.
[72] Philippa Marrack,et al. Autoimmune disease: why and where it occurs , 2001, Nature Medicine.
[73] M. Mahler,et al. A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1 , 2001, Journal of Molecular Medicine.
[74] A. Silverstein. Autoimmunity versus horror autotoxicus: The struggle for recognition , 2001, Nature Immunology.
[75] K. Fong,et al. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus. , 2001, International immunology.
[76] M. Hearth-Holmes,et al. Prevalence of Active Hepatitis C Virus Infection in Patients with Systemic Lupus Erythematosus , 2001, The American journal of the medical sciences.
[77] M. Mahler,et al. Fine-specificity of the anti-CENP-A B-cell autoimmune response , 2000, Journal of Molecular Medicine.
[78] B Westerlund-Wikström,et al. Peptide display on bacterial flagella: principles and applications. , 2000, International journal of medical microbiology : IJMM.
[79] R. Lührmann,et al. The C-terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-cell Epitope for Anti-Sm Autoantibodies* , 2000, The Journal of Biological Chemistry.
[80] G. Pruijn,et al. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis , 2000, Arthritis research.
[81] T. Lowe,et al. Fibrillarin-associated box C/D small nucleolar RNAs in Trypanosoma brucei. Sequence conservation and implications for 2'-O-ribose methylation of rRNA. , 2000, The Journal of biological chemistry.
[82] M. Mahler,et al. Identification of an α-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25β autoantigen using immobilized overlapping synthetic peptides , 2000, Journal of Molecular Medicine.
[83] I. Pettersson,et al. Key residues revealed in a major conformational epitope of the U1-70K protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[84] James,et al. Shared Early Autoantibody Recognition Events in the Development of Anti‐Sm B/B' in Human Lupus , 1999, Scandinavian journal of immunology.
[85] J. Schneider-Mergener,et al. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. , 1998, The Journal of clinical investigation.
[86] J. Harley,et al. B‐cell epitope spreading in autoimmunity , 1998, Immunological reviews.
[87] B. Diamond,et al. Immunization with a Peptide Surrogate for Double-stranded DNA (dsDNA) Induces Autoantibody Production and Renal Immunoglobulin Deposition , 1998, The Journal of experimental medicine.
[88] Jerrold S. Levine,et al. Apoptosis and autoimmunity , 1997, Current opinion in nephrology and hypertension.
[89] E. Tan,et al. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. , 1997, Journal of immunology.
[90] J. Harley,et al. Peptide autoantigenicity of the small nuclear ribonucleoprotein C. , 1995, Clinical and experimental rheumatology.
[91] E. Tan,et al. Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .
[92] S. Turley,et al. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. , 1995, Journal of immunology.
[93] R. Burlingame,et al. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. , 1994, The Journal of clinical investigation.
[94] J. Mott,et al. Biochemical diversity in a phage display library of random decapeptides. , 1993, Gene.
[95] M. Fritzler,et al. Epitope mapping of histone 5 (H5) with systemic lupus erythematosus, procainamide-induced lupus and hydralazine-induced lupus sera. , 1993, Molecular immunology.
[96] M. Blüthner,et al. Cloning and characterization of the cDNA coding for a polymyositis- scleroderma overlap syndrome-related nucleolar 100-kD protein , 1992, The Journal of experimental medicine.
[97] R. Houghten,et al. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery , 1991, Nature.
[98] G. Blobel,et al. cDNA cloning and sequencing of human fibrillarin, a conserved nucleolar protein recognized by autoimmune antisera. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[99] M. Fritzler,et al. Antibodies from patients with systemic lupus erythematosus and drug-induced lupus bind determinants on histone 5 (H5). , 1990, Molecular immunology.
[100] M. Jannatipour,et al. Heterologous expression and epitope mapping of a human small nuclear ribonucleoprotein-associated Sm-B'/B autoantigen. , 1990, Journal of immunology.
[101] E. Tan,et al. Anti-fibrillarin autoantibodies in mercury-treated mice. , 1989, Clinical and experimental immunology.
[102] T. Mimori,et al. The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes. , 1988, The Journal of clinical investigation.
[103] E. Tan. Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity , 1988, The Pediatric infectious disease journal.
[104] H. M. Geysen,et al. Strategies for epitope analysis using peptide synthesis. , 1987, Journal of immunological methods.
[105] P. Cary,et al. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. , 1985, Journal of immunology.
[106] K. Elkon,et al. Lupus autoantibodies target ribosomal P proteins , 1985, The Journal of experimental medicine.
[107] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[108] J. Hardin,et al. The major core histone antigenic determinants in systemic lupus erythematosus are in the trypsin‐sensitive regions , 1984, FEBS letters.
[109] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[110] H. Kunkel,et al. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. , 1966, Journal of immunology.
[111] A. La Cava,et al. Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus. , 2009, Expert opinion on biological therapy.
[112] L. Klareskog,et al. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. , 2008, Arthritis and rheumatism.
[113] Atlanta,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.
[114] M. McClain,et al. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. , 2006, Arthritis and rheumatism.
[115] M. McClain,et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry , 2005, Nature Medicine.
[116] M. Rowley,et al. Phage display for epitope determination: a paradigm for identifying receptor-ligand interactions. , 2004, Biotechnology annual review.
[117] J. Koch,et al. Affinity Purification and Competition Assays Using Solid-Phase Oligopeptides , 2002 .
[118] Ronald Frank,et al. SPOT Synthesis — Scope of Applications , 2002 .
[119] E. Möncke-Buchner,et al. Analysis of Protein-DNA Interactions , 2002 .
[120] C. Schneider,et al. Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology. , 1999, Autoimmunity.
[121] E. Bautz,et al. Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries. , 1996, Journal of immunological methods.
[122] E. Tan,et al. Autoantibodies in the diagnosis of systemic rheumatic diseases. , 1995, Seminars in arthritis and rheumatism.
[123] Kit S. Lam,et al. A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.
[124] R. Lührmann,et al. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.